Invesco Biotechnology & Genome ETF
PBE
PBE
94 hedge funds and large institutions have $82M invested in Invesco Biotechnology & Genome ETF in 2025 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 15 increasing their positions, 36 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
58% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 36
Holders
94
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$757K | |
| 2 | +$633K | |
| 3 | +$343K | |
| 4 |
RA
RFG Advisory
Birmingham,
Alabama
|
+$290K |
| 5 |
Jones Financial Companies
Des Peres,
Missouri
|
+$180K |
Top Sellers
| 1 | -$878K | |
| 2 | -$683K | |
| 3 | -$464K | |
| 4 |
JP Morgan Chase
New York
|
-$451K |
| 5 |
JIC
Joel Isaacson & Co
New York
|
-$427K |